Global resurgence of tuberculosis is troubling
One third of the world's population has latent tuberculosis, and
nine million new cases of active tuberculosis emerge annually, which
results in up to three million deaths. In a clinical review, Chan and
Iseman (p 1282) discuss the challenges associated with treating
tuberculosis. Patients' non-adherence is the most common cause of
treatment failure and acquired drug resistance, but predicting non-compliance is difficult. The immediate challenges for the control
of tuberculosis are developing treatment regimens that are shorter or
less frequent for patients. Long term prospects include improved vaccines.
CiteULike 
Complore 
Connotea 
Del.icio.us 
Digg 
Reddit 
StumbleUpon 
Technorati What's this?
Relevant Article
- Current medical treatment for tuberculosis
- Edward D Chan and Michael D Iseman
BMJ 2002 325: 1282-1286.[Extract] [Full Text] [PDF]
This Article
- Respond to this article
- Alert me when this article is cited
- Alert me when responses are posted
- Alert me when a correction is posted
Services
- Email this article to a friend
- Find similar articles in BMJ
- Add article to my folders
- Download to citation manager
- Request Permissions
Citing Articles
Google Scholar
Related Content
Bookmark with
What's new
Latest blogs
Find BMJ on:
Services
Tools
Online poll
Resources
Rapid responses for this article
There are no rapid responses for this article. Print issues
